Table of Contents
Long-acting controlled substance formulations are commonly used in the management of chronic conditions such as pain, ADHD, and opioid dependence. These formulations are designed to release medication gradually over an extended period, reducing dosing frequency and improving patient adherence.
Common Brand Names of Long-Acting Controlled Substances
Several brand names are associated with long-acting formulations of controlled substances. These brands are widely recognized in clinical practice and are often preferred for their reliability and consistent release profiles.
Long-Acting Opioids
- OxyContin – Oxycodone extended-release
- Duragesic – Fentanyl transdermal patches
- Exalgo – Hydromorphone extended-release
- MS Contin – Morphine sulfate extended-release
Long-Acting Stimulants
- Concerta – Methylphenidate extended-release
- Adderall XR – Amphetamine and dextroamphetamine extended-release
- Vyvanse – Lisdexamfetamine
Long-Acting Opioid Antagonists
- Vivitrol – Naltrexone for opioid dependence
Considerations When Using Long-Acting Formulations
Healthcare providers must carefully consider the potential for overdose, misuse, and interactions with other medications. Patients should be monitored regularly for efficacy and adverse effects. Proper storage and disposal of these medications are essential to prevent misuse.
Conclusion
Understanding the brand names of long-acting controlled substance formulations helps in ensuring proper prescribing, dispensing, and patient education. These formulations play a critical role in managing chronic conditions while aiming to minimize risks associated with controlled substances.